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ABSTRACT
A very high rate of multidrug resistance (MDR) seen
among Gram-negative bacteria such as Escherichia,
Klebsiella, Salmonella, Shigella, etc. is a major threat
to public health and safety. One of the major virulent
determinants of Gram-negative bacteria is capsular
polysaccharide or K antigen located on the bacte-
rial outer membrane surface, which is a potential
drug & vaccine target. It plays a key role in host–
pathogen interactions as well as host immune eva-
sion and thus, mandates detailed structural informa-
tion. Nonetheless, acquiring structural information
of K antigens is not straightforward due to their in-
nate enormous conformational flexibility. Here, we
have developed a manually curated database of K
antigens corresponding to various E. coli serotypes,
which differ from each other in their monosaccha-
ride composition, linkage between the monosaccha-
rides and their stereoisomeric forms. Subsequently,
we have modeled their 3D structures and devel-
oped an organized repository, namely EK3D that can
be accessed through www.iith.ac.in/EK3D/. Such a
database would facilitate the development of an-
tibacterial drugs to combat E. coli infections as
it has evolved resistance against 2 major drugs
namely, third-generation cephalosporins and fluo-
roquinolones. EK3D also enables the generation of
polymeric K antigens of varying lengths and thus,
provides comprehensive information about E. coli K
antigens.
INTRODUCTION
Escherichia coli is a Gram-negative bacterium that belongs
to Enterobacteriaceae family. It is a common cause for uri-
nary tract infections (including kidney infections), blood-
stream infection, intra-abdominal infections like peritoni-
tis, skin & soft tissue infections, neonatal meningitis and
foodborne infections (1). Certain pathogenic strains of E.
coli have increasingly become resistant to many antibacte-
rial drugs and are a major threat to public health and safety.
For instance, two major drugs namely, third-generation
cephalosporins and fluoroquinolones that are widely under
use have become ineffective against many E. coli infections.
Since E. coli can readily acquire resistance either through
mutations as against fluoroquinolone (2) or throughmobile
genetic elements as against third-generation cephalosporins
(3), they may also quickly develop resistance against car-
bapenem, a drug that is considered to be ‘the last resort’
to treat many complicated bacterial infections (4). Further,
the inherent characteristic ofE. coli to pass the antibacterial
resistance along with the genetic material allows other bac-
teria to become drug resistant, thus, facilitating the global
spread of antibacterial resistance (5).
Multiple virulence factors in a bacteria act individually
or together at different stages of infection to facilitate host–
pathogen interaction as well as disease pathogenesis. Cap-
sular polysaccharide (CPS) or K antigen is a covalently
attached surface associated virulence factor that conceals
the bacterial surface and helps it to escape from host self-
defensemechanism (6–8). Though it can be a potential drug
as well as vaccine target, the mechanism about how the
capsule manipulates the host self-defense mechanism is not
clearly understood. E. coli has more than 80 such K anti-
gens which in combination with O and H antigens leads
to about 50 000–100 000 or more serotypes (6,9). Each K
antigen differs from each other by their sugar composi-
tion, linkage between the sugars and their stereoisomeric
forms. However, deriving the structural information of K
antigens by X-ray or NMR is not straightforward due to
their inbuilt conformational flexibility. Any such informa-
tion would ease the vaccine and drug discovery process
against E. coli infections.
Here, we have developed a database named as EK3D,
an E. coli K antigen 3-Dimensional Structure Database
(www.iith.ac.in/EK3D/). It is a repository of 72 E. coli K
antigens that provides information about sugar composi-
tions, their anomeric and enantiomeric forms and linkages
between the sugarmonomers. The database also has the col-
lection of 3D structural models of the K antigen repeating
units that are derived from the above information. As the
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classification of E. coli into group 1, 2, 3 and 4 is developed
based on K antigens (6,10), the database also contains in-
formation about the group based serotyping of E. coli K
antigens. As the capsules are molecules of 100–10000 kD
multimers, the database also provides the facility to gener-
ate polymeric structures of K antigen repeat units. Its note-
worthy that a similar effort has been made earlier to have
an organized repository of E. coliO-antigen structures that
eventually resulted in the development of E. coli O-antigen
database (ECODAB) (11).
MODELING OF E. coli K ANTIGEN STRUCTURES
Sugar composition and linkage information of E. coli K
antigens that are derived from structural methods such
as NMR and X-ray and chemical methods like hydrol-
ysis, sequential Smith degradation, methylation analysis,
etc. are used in the modeling of K antigen repeating units.
Initial models for K antigens with normal sugar moi-
eties are modeled from Glycam (Woods Group. (2005–
2015) GLYCAM Web. Complex Carbohydrate Research
Center, University of Georgia, Athens, GA. (http://www.
glycam.com)) and SWEETII (12) web-servers. Neverthe-
less, K antigens with unusual sugars like KDO (both
pyranose and furanose forms), hexulosonic acid, Quip-
4N-Malate, sugar P (2,3-diacetamido-2,3,6-trideoxy--L-
mannopyranose), pyruvate, ribitol etc. as well as with
highly diversified substituents like O/N-acetylation, phos-
phorylation & glycerolization are modeled manually us-
ing Pymol (The PyMol Molecular Graphics System, Ver-
sion 1.3, Schrodinger, LLC, 2010). Subsequently, these
models are energy minimized using Generalized Born
with a simple SWitching (GBSW) implicit solvent model
(13,14) using CHARMM 36 forcefield (15–20) to remove
the steric hindrance and optimize the internal geometry.
CHARMMall atom additive empirical carbohydrate force-
field has been derived carefully from small molecules such
as ethanol, methanol, isopropanol, etc. that contains the
fragments of the pyranose/furanose and transferred to the
full pyranose/furanose form and finally verified by its re-
producibility of the experimental as well as quantum me-
chanical properties (18–20). Similarly, the linkage between
them has been derived from model compounds tetrahy-
dropyran (THP) and tetrahydrofuran (THF) and then opti-
mized using quantum mechanical calculations and verified
by NMR data (21). All the K antigens that are modeled
with the CHARMM 36 carbohydrate force field are sub-
jected to 1500 steps of steepest descent followed by 1500
steps of adopted basis Newton-Raphson energy minimiza-
tion methods with a non-bonded cut-off of 16A˚. It is note-
worthy that we have developed the forcefield for unusual
sugars, various substituents and linkages that are not avail-
able in CHARMM to carryout energy minimization. Vari-
ous steps involved in the modeling of K antigen repeating
units are illustrated in Figure 1.
Due to the variability in the substituents at various posi-
tions of the furanose and pyranose sugars, a special nam-
ing scheme has been developed for EK3D (Figure 2). Each
K antigen is assigned a specific EK3D ID with a prefix of
‘EK’ followed by the K antigen number. Note that as the
structural information about K antigens K17, K21, K59,
K61, K63, K65, K67, K69, K73, K76, K77 and K88 are
unavailable at present and they have not been included in
the database.
Modeled 3D structural information of 72 E. coli K anti-
gens have been stored in a Linux based machine. Access
to the data is enabled through Apache web-server manage-
ment system and PHP web-server scripting language.
FUNCTIONALITY OF THE WEB-SERVER
Homepage of the web-server contains general description
about the server followed by description and classifica-
tion of K antigens based on their biosynthesis and sur-
face expression mechanisms (Figure 3). E. coli K antigen
structures that are classified into groups 1 to 4 can be ac-
cessed under the navigation bar heading ‘K antigen struc-
tures’. By clicking the appropriate EK3D ID, the descrip-
tion about the particular K antigen chemical structure and
its schematic representation based on the nomenclature de-
veloped for glycans by the Consortium for Functional Gly-
comics (CFG) (22) appears alongwith the download option
for the Cartesian coordinates. Visualization of the 3D struc-
ture of the corresponding K antigen is also enabled using a
portable network graphics (PNG) format file followed by an
interactive Jsmol applet (JSmol: an open-source HTML5
viewer for chemical structures in 3D. http://wiki.jmol.org/
index.php/JSmol). Using the Jsmol applet, the user can
bring changes to the representation of the molecule, back-
ground, etc.
The user can also search for the K antigen using a specific
monosaccharide or a disaccharide fragment or a keyword
(Figure 4). This has been facilitated by choosing ‘Search
EK3D’ option, which directs the user to a different web-
page. Subsequently, the user is given the choice to opt for
anyone of the aforementioned search option. As illustrated
in Figure 4, when the user chooses a specific monosaccha-
ride (Figure 4(B) top), all EK3D IDs that contain the given
monosaccharide unit will be displayed. Similarly, the user
can search for the K antigens that has specific disaccharide
unit by specifying the sugars from the non-reducing end to
reducing end along with the linkage information (Figure
4(B) middle). As before, this will display the EK3D IDs that
contain the disaccharide unit. Additionally, a general key-
word search can be carried out (Figure 4(B) bottom).
It’s noteworthy that as EK3D uses a specific nomencla-
ture for the residue names, description about the EK3D
naming scheme (Figure 2) and anEK3Dnomenclature con-
verter is included in the documentation page.
K ANTIGENMULTIMER GENERATION
As K antigens exist in multimeric forms of 100–10000 kD,
EK3D has the option to generate the K antigen multi-
mers. For multimer generation, EK3D employs two meth-
ods namely, flexible multimer modeling (FMM) and rigid
multimer modeling (RMM).
In FMM, choice is given to the user to choose their own
inter-repeat glycosidic torsion angles O(n)i-1–C(j)i-1–O(j)i–
C(k)i (φ) (note that ‘n’ stands for ring oxygen number) and
C(j)i-1–O(j)i–C(k)i–C(k-1)i (ψ) (for j–k linkage). Note that
atom numbers are represented by j and k and the residue
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Figure 1. Schematic diagram showing the various steps involved in data curation and modeling of E. coli K antigen structures in EK3D.
Figure 2. Naming scheme followed in EK3D to represent monosaccharides. (A) The four letter code encompasses the anomeric form of the sugar ( or 
or 0) at the first position, followed by the name of the sugar at the second position. For instance, A at second position represents galactose. The third letter
is assigned to chemical modifications such as phosphorylation and acetylation: A at the third position corresponds to O acetylation at the first carbon
atom and J corresponds to N acetylation at the second carbon atom. The fourth letter indicates the furanose form of the sugar. (B) Examples for schematic
and chemical representations of monosaccharides and the associated EK3D naming scheme.
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Figure 3. Snapshots illustrating the workflow in EK3D (clockwise). The navigation bar ‘About K antigens’ provides information regarding K antigen
functions and its classification into groups 1, 2, 3 and 4. Subsequent navigation bar ‘Antigen structures’ contains information about all the manually
curated K antigens that are available in EK3D. ‘Multimer modeling’ navigation bar allows the user to opt for two different methods namely, rigid multimer
modeling (RMM) and flexible multimer modeling (FMM) to model the multimers of K antigens. Refer Figure 5 for more details about FMM and RMM.
The ‘Documentation’ navigation bar explains about the usage of the database and ‘Search EK3D’ option allows the user to search the database using a
specific monosaccharide or disaccharide fragment or keyword. Additionally, ‘Sugar converter’ option given in the document converts the sugar name into
EK3D nomenclature.
numbers by i and i-1. In exception to the above, when k= 1,
ψ is defined as C(j)i-1–O(j)i–C(k)i–C(k+1)i. The above def-
inition of φ and ψ are in the direction of decremental or-
der of the main chain residue number. Modeling the multi-
mer can be achieved through coordinate transformation us-
ing virtual bond method, which has been successfully used
in the conformational analysis of polypeptide (23), polynu-
cleotide (24–26) and polysaccharide (27) systems. FMMop-
tion is enabled under ‘Multimer generation’ navigation bar.
Consequently, the user has to enter the appropriate EK3D
ID along with the choice for the number of repeating units
and the desired inter-repeat glycosidic torsion angles to gen-
erate the multimer (Figure 5A). As per the user’s choice of
inter-repeat glycosidic torsion angles K antigen’s with dif-
ferent conformations can be generated.
Nevertheless, in RMM, φ and ψ are manually optimized
for each K antigen so as to have a steric free model with
a glycosidic angle ∼115◦. These values are stored as a part
of the database and are used when the multimer generation
is performed. Thus, in RMM, server generated glycosidic
torsion angles are used. As before, RMM option can be in-
voked under ‘Multimer generation’ navigation bar. The user
has to simply specify the EK3D ID of the appropriate K
antigen and the required number of repeating units to gen-
erate the multimer.
More details about the FMM and RMMmethodologies
can be seen in the Supplementary materials. In both FMM
and RMM the generated K antigen multimer coordinates
can be downloaded as well as visualized in the web-page
using Jsmol.
CONCLUSION
Due to the innate conformational flexibility of oligosaccha-
rides, acquiring their 3D structural information is very chal-
lenging. As the bacterial surface associatedK antigen is one
of the major virulent determinants that help the bacteria in
host-immune evasion, its structural information is impor-
tant to understand the underlying mechanism behind how
the bacteria escapes from host self-defense as well as to de-
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Figure 4. Search option in EK3D. (A) Through ‘Search EK3D’ option, the user can search for a monosaccharide or a disaccharide fragment or a keyword.
A specific (B, top) monosaccharide and (B, middle) disaccharide along with the glycosidic linkage can be selected from the dropdown menu. (B, bottom)
Additionally, a keyword search has also been implemented, where the user can search the database using a specific keyword.
velop antibacterial drug(s) and vaccine(s). Structural infor-
mation about K antigens of E. coli (which rapidly evolves
multidrug resistance) such as the composition of monosac-
charides, linkages between them and their enantiomeric and
anomeric forms have been investigated in different studies
over past three decades. Here, we have developed a repos-
itory that contains the aforementioned information of 72
K antigen structures of E. coli as well as their modeled 3-
dimensional structures. As K antigens exist as multimers,
the server also facilitates the multimer generation of the K
antigens. It’s well-known that a supramolecular assembly is
involved in the surface expression and anchorage of K anti-
gens. Though the structures of some of the surface expres-
sion (Wza, PDB ID: 2J58) and anchorage (Wzi, PDB ID:
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Figure 5. Multimer modeling tool. (A) In flexible multimer modeling (FMM), while the intra-repeat glycosidic torsion angles are fixed, the user can choose
the inter-repeat glycosidic torsion angles of their choice along with the number of repeating units. (B) In rigid multimer modeling (RMM), both the inter-
and intra-residue glycosidic torsion angles are fixed and the user has to input the required number of repeating units. Schematic representation of K32 that
has been used as an example here is shown in (A, Right).
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2YNK) proteins are known, precise information about their
interaction with K antigens is unavailable. Thus, the struc-
tural information provided here could be used as a starting
model for modeling studies such as docking and molecular
dynamics simulations to understand the conformational dy-
namics of K antigens as well as their surface expression and
anchorage mechanism(s). In fact, these models can also be
used as a starting model for NMR structure refinement. K
antigens may also be expressed in a low molecular weight
form by covalent attachment to the lipid A core (known
as KLPS), a characteristic quite common in group 1. The
K antigen structures provided here can thus be used in the
modeling of KLPS and facilitate the understanding of their
conformational behavior. Thus, EK3D may serve as an im-
portant tool for researchers to elucidate the role of K anti-
gens in host–pathogen interaction as well as in antibacterial
drug and vaccine development.
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EK3D is freely accessible via internet through www.iith.ac.
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